NEW YORK (GenomeWeb News) – Genelabs Technologies this week said CFO Matthew Loar will resign on Sept. 1. The company said he has taken a job at an undisclosed biotech company.
James Smith, Genelabs’ president and CEO, will assume Loar’s duties until a permanent replacement is found.
In the same statement, Genelabs said it hired Peter Young to be its vice president of biology. Young comes to Genelabs from Celera Genomics, where he held the same position.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.